Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-controlled, dose-finding study

Fig 2

Study design.

The area enclosed by the dotted line indicates the double-blind treatment phase. *Patients with prior cinacalcet treatment.

Fig 2

doi: https://doi.org/10.1371/journal.pone.0204896.g002